Return to homepagePandemic Pact

CoviCompare-P: refining knowledge of the immune responses of people aged 65 and over and COVID-19-experienced individuals vaccinated with Pfizer/BioNTech

Grant number: ANRS0002S

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Inserm

  • Principal Investigator

    N/A

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The objective is to evaluate in detail the immune responses induced by the Pfizer/BioNTech vaccine in people aged 65 and over, and to compare those of people having already contracted COVID-19 with those of people who have never had it. The participants will be assigned to the same age groups as for CoviCompare-m in addition to three other categories (150 people who have never contracted COVID will receive two vaccine doses and 150 participants having already had COVID will receive one).